Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Bibeau

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 26, 2024
The ESMO Tumour-Agnostic Classifier and Screener (ETAC-S): a tool for assessing tumour-agnostic potential of molecularly guided therapies and for steering drug developmentC B Westphalen, D Martins-Branco, J R Beal, et al.
Bulletin Du Cancer|October 2, 2001
[Standards, options and recommendations: practice guidelines for difficult diagnosis in surgical pathology or cytopathology in cancer patients]J M Coindre, M P Blanc-Vincent, F Collin, et al.
Annales De Pathologie|April 20, 2004
[HER2 gene amplification assay: is CISH an alternative to FISH?]Yves Denoux, Laurent Arnould, Maryse Fiche, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 19, 2025
Effect of 5 years of CT-scan and CEA follow-up on survival endpoints in patients with colorectal cancer: the PRODIGE-13 FFCD phase III trialC Lepage, J-M Phelip, L Cany, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 13, 2015
Professional risks when carrying out cytoreductive surgery for peritoneal malignancy with hyperthermic intraperitoneal chemotherapy (HIPEC): A French multicentric surveyG Ferron, L Simon, F Guyon, et al.
ESMO Open|January 5, 2021
Clinical and molecular practice of European thoracic pathology laboratories during the COVID-19 pandemic. The past and the near futureP Hofman, M Ilié, E Chamorey, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 26, 2024
The ESMO Tumour-Agnostic Classifier and Screener (ETAC-S): a tool for assessing tumour-agnostic potential of molecularly guided therapies and for steering drug developmentC B Westphalen, D Martins-Branco, J R Beal, et al.
Bulletin Du Cancer|October 2, 2001
[Standards, options and recommendations: practice guidelines for difficult diagnosis in surgical pathology or cytopathology in cancer patients]J M Coindre, M P Blanc-Vincent, F Collin, et al.
Annales De Pathologie|April 20, 2004
[HER2 gene amplification assay: is CISH an alternative to FISH?]Yves Denoux, Laurent Arnould, Maryse Fiche, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 19, 2025
Effect of 5 years of CT-scan and CEA follow-up on survival endpoints in patients with colorectal cancer: the PRODIGE-13 FFCD phase III trialC Lepage, J-M Phelip, L Cany, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 13, 2015
Professional risks when carrying out cytoreductive surgery for peritoneal malignancy with hyperthermic intraperitoneal chemotherapy (HIPEC): A French multicentric surveyG Ferron, L Simon, F Guyon, et al.
ESMO Open|January 5, 2021
Clinical and molecular practice of European thoracic pathology laboratories during the COVID-19 pandemic. The past and the near futureP Hofman, M Ilié, E Chamorey, et al.
Pageof 5